Prior to founding our company, Dr. Eltoukhy held various positions at Illumina, Inc. from August 2008 to December 2012, including Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. IonBombardmentEnhanced Diffusion During the Growth of Sputtered Superlattice Thin Films. There are barriers to traditional standard-of-care testing and screening modalities that a simple blood test, which is easier, faster, and less invasive, can help overcome. Interlayer Diffusion in InSb/GaSb Superlattice Structure Grown by Multitarget RF Sputtering, Surface Properties of Magnetic Rigid Disks for HighDensity Data Storage. We first launched our liquid biopsy back in 2014. Petition for Dissolution of Marriage/Domestic Partnership. Guardant Health Co-founder & CEO 2013 Board and Advisor Roles Number of Current Board & Advisor Roles 1 Helmy Eltoukhy is the Board Member at Guardant Health. Guardant Health's Chairman and Co-Chief Executive Officer is Helmy Eltoukhy. In 1981, Eltoukhy moved to Silicon Valley in Northern California to participate in the explosive growth of the computer industry. Another $30 million-plus purchase was made in the same neighborhood in early November when an LLC associated with Helmy Eltoukhy, co-founder of $5 billion Guardant Health, bought a home for $30.25 . Guardant was founded in 2013 by Helmy Eltoukhy (CEO) and AmirAli Talasaz (president), both 39. There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. You really need to get the necessary clinical evidence to prove to oncologists that this improves upon the current standard of care or serves an unmet medical need. Its possible to fundamentally bring about breakthrough impact by focusing on simple things. Eltoukhy's graduate education included a Master of Science degree in Metallurgical Engineering from the Cairo University School of Engineering as well as graduate studies at the American University in Cairo from 1973 to 1975 and a PhD from the University of Illinois, Urbana-Champaign in 1978. a method of forming an isotropic texture having a selected summit density and surface roughness in a selected inner-diameter annular zone of a thin-film medium substrate having a polished metal coating on the substrate. I had lost my dearest friends and family to cancer, Talasaz says. Get notified the next time Helmy Eltoukhy buys or sells Guardant Health stock. PALO ALTO, Calif., (BUSINESS WIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that it will present data. Unlike innovation in broad technology, in healthcare, you have the added barriers of clinical evidence, regulatory approval, reimbursement, etc. Acquired by Illumina in 2008, Avantome . ; Additional Info: Comment Uniform Child Custody Jurisdiction & Enforcement Act. 8th Annual Breakthrough Prize Ceremony - Arrivals. During the last year, Guardant Health insiders bought shares 2 times. (Id. Under Eltoukhys direction as CEO, Guardant Health raised over one billion dollars in financing, launched three products, established collaborations with oncology researchers, and gained recognition as a healthcare innovator inliquid biopsyapproaches used for cancer diagnosis and research. 2018-10-09, San Mateo County Superior Courts | Family | We use interviews to draw out stories that are both empowering and actionable. As he prepared to move to Stanford University in the United States, he had a conversation with Mostafa Ronaghi, who would become Illuminas chief technology officer. In 2006 Helmy Eltoukhy earned a PhD in electrical engineering from Stanford, authoring his doctoral thesis, called "An integrated system for de novo DNA sequencing." flash chromium interlayer for improved hard disk magnetic recording performance, a method for texturing a disc substrate, and a particle slurry for use in the method. Helmy Eltoukhy. Whats happened in the last decade has really been the tipping point. FinancialFinancial info for ELTOUKHY, HELMY; eFile Online Payment Receipt # 2023-005493-HOJ ELTOUKHY, HELMY $20.00, FinancialFinancial info for ELTOUKHY, HELMY; Transaction Assessment $20.00, DocketStipulation. Last year our Guardant360 CDx test became the first FDA-approved comprehensive liquid biopsy for any advanced solid cancer, helping to overcome remaining skepticism about the technology and help set the stage for earlier cancer detection. Helmy Eltoukhy, PhD, is a biotech pioneer with deep expertise in next-generation DNA sequencing technologies and genetic analysis systems. Helmy Eltoukhy is an American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. ; Additional Info: Comment MSC - 1/12/23 at 2 PM, Family Law Status Conference. Growth and Electrical Properties of SputterDeposited SingleCrystal GaSb Films on GaAs Substrates. A simple blood test to detect cancer at all stages of the disease has the power to change the world by increasing testing and screening rates which will help curb cancer mortality rates once and for all. We certainly believed that our liquid biopsy could make a difference in patient care, but were surprised to discover all the unexpected ways it could. It has raised $1.6 billion, according to Pitchbook. The Inception Overview. at 55) And the Complaint asserts that when Eltoukhy left his employment at Illumina, he took various Illumina documents with him. Your career? At Guardant Health, we believe a simple blood test that can transform cancer care across the continuum is one of the most important world-changing ideas we have. That month, Mr. Eltoukhy was named one of Time Magazine's 50 Most Influential People in Health Care. Information on this page was last updated on 3/15/2023. As the CEO of Guardant Health, Inc., Dr. Eltoukhy earned a total compensation package of $13,665.00 in 2021. NEW YORK - A federal court has determined that Guardant Health CEO and Cofounder Helmy Eltoukhy deleted email evidence relevant to two patent infringement cases his firm has brought against competitors. Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the company's Co-Chief Executive Officer since August 2021. About half of San Mateo Countys 27 submarkets, including Atherton, saw single-family sales volume drop from September to October, according to MLSListings data. I think with innovation, its vitally important to have confidence, that audaciousness, that optimism and can-do spirit, but I think a challenge arises when this is not combined with intellectual humility particularly when it comes to science and healthcare. This meant she was now a candidate for a common ovarian cancer chemotherapy. Its solutions include treatment selection, recurrence detection, and early detection. FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. ; Additional Info: Comment Final Declaration of Disclosure and Income & Expense Declaration filed. Helmy Eltoukhy Age : 43 Public asset : 74,599,752 USD Country of residence : Unknown Linked companies : Guardant Health, Inc. The co-founder of startups Avantome and Guardant Health, Eltoukhy was named to Time Magazine's inaugural 50 Most Influential People in Healthcare (2018) and Fortune's 40 under 40 (2017). Named as aWorld Economic ForumTechnology Pioneer and to Fierce Biotech's Fierce 15 list. Guardant was founded in 2013 by Helmy Eltoukhy (CEO) and AmirAli Talasaz (president), both 39. For Talasaz, the potential of the technology comes back to patients. How do I contact Helmy Eltoukhy? UniCourt uses cookies to improve your online experience, for more information please see our Privacy Policy. Eltoukhy has also authored many patents and publications in semiconductor and magnetic thin film technology. Guardant Health Board Member Related Hubs Education The blood is full of pieces of DNA shed by cells. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Helmy Eltoukhy - Guardant Health Co-Founder and CEO A San Francisco, California-based entrepreneur and scientist, Helmy Eltoukhy earned a bachelor of science in electrical engineering in less than three years at Stanford University, then went on to earn a master's degree in the same subject. Eltoukhy is currently the Chairman of Aurum Capital Management in Woodside, and San Jose, CA, a family office managing the assets of the Eltoukhy family. Why is this public record being published online? ; Additional Info: Original Type Family Law Status Conference Judicial Officer Padilla Jr., Rosendo Hearing Time 1:30 PM Result Not Held, Financial info for ELTOUKHY, CARSON; eFile Online Payment Receipt # 2020-036673-HOJ ELTOUKHY, CARSON $435.00, Financial info for ELTOUKHY, CARSON; Transaction Assessment $435.00, Financial; ELTOUKHY, CARSON; Total Financial Assessment $515.00; Total Payments and Credits $515.00, Cause Of Action. In addition, Meghan Joyce, COO, and EVP of Platform at Oscar Health will join the Board as an Independent Director. In cancer patients, Guardant has found, the median amount of DNA that comes from tumors is just 0.4%. In-depth Interviews with Authorities in Business, Pop Culture, Wellness, Social Impact, and Tech. Lets now move to the main focus of our interview. Eltoukhy didnt respond to requests for comment. Guardant Health's current Chief Executive Officer is Helmy Eltoukhy. Eltoukhy, Helmy, Theres been a confluence of different technologies, different extraction methodologies, and different high-powered bioinformatic tools along with affordability of applying next-generation sequencing to routine testing that have really enabled us to get much more sensitive and specific in terms of seeing these trace fragments of either DNA or proteins that are contained within a tube of blood. Eltoukhy, Carson, Sell-side analysts at Cowen, Leerink Partners, J.P. Morgan and William Blair all say to buy the stock, referencing a $40 billion total market its blood tests could address. Keeping Black Mirror and the Law of Unintended Consequences in mind, can you see any potential drawbacks about this idea that people should think more deeply about? Superior Courts Post a comment / Mar 21, 2022 at 1:43 PM. DocketPetition for Dissolution of Marriage/Domestic Partnership. Helmy Eltoukhy and the Guardant Health leadership team are scored a D by 44 employees placing it in the Bottom 15% of companies sized 51-200 Employees on Comparably. To be honest, there arent many significant drawbacks to liquid biopsy. Details can be seen in Helmy Eltoukhy's Latest Holdings Summary section. Service Date: 02/1/2022, DocketClerk's Notice of Hearing. Powered and implemented by Interactive Data Managed Solutions. ; Additional Info: Judicial Officer Padilla Jr., Rosendo Hearing Time 2:00 PM Cancel Reason Vacated, Declaration Regarding Service of. She was administered the therapy and had a fantastic response with her disease going into remission. Helmy is an entrepreneur and pioneer in the biotech industry. . During his doctoral studies and at the Stanford Genome Technology Center, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-generation sequencing under several National Human Genome Research Institute grants. Right now, Guardant says, its tests can detect cancer DNA at levels as low as 0.02% of the total amount of DNA in a patients blood. DocketDeclaration Under UCCJEA. Superiorwith Greenberg, Susan presiding. See the full leadership team at Craft. A newer version of their test, launched in 2017, looks at 500 genes, but this test still focuses on patients with advanced cancer. Significant News Only. "I decided to dedicate my life [+] to this disease," he told Forbes. In 2007, he co-founded Avantome to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing until its acquisition by Illumina in August 2008. Once you do that, you need to make sure payers will cover the test. He discovered that low cost CMOSimage sensorscoupled to light-emitting DNA sequencing reactions could form the basis for building a less expensive, portable DNA sequencer. MOUNTAIN VIEW, CALIFORNIA - NOVEMBER 03: Helmy Eltoukhy and Carson Eltoukhy attend the 2020 Breakthrough Prize Ceremony at NASA Ames Research Center on November 03, 2019 in Mountain View, California. As CEO of the company, he helped raise more than $2.5 billion in funding for the company and took it public in October 2018. As Health Plans Address Social Determinants, UnitedHealth Group To Make 2.5 Million Home Visits This Year, Englands Nurses To Strike Again After Rejecting Pay Deal. Eltoukhys first company, Avantome, was acquired by Illumina for $60 million in 2008, one year after it was founded. 2020-02-26. There are 14 older and 1 younger executives at Guardant Health Inc. We will email you when the process is complete. All allegations herein are made on information and belief except where otherwise indicated. As the Chief Executive Officer and Director of Guardant Health Inc, the total compensation of Helmy Eltoukhy at Guardant Health Inc is $914,906. Learn More on Helmy Eltoukhy's trading history. Discover the immediate steps you need to take now. For full print and download access, please subscribe at https://www.trellis.law/. Over the last few years, we have made tremendous progress with payer coverage and have 200 million Americans covered for Guardant360, but there are is still more work to do until every individual is covered for the test. [1][2][3] and served on a number of other university boards, including the board of directors of the International House at UC Berkeley, where he was the Treasurer[4], as well as the board of Cal State East Bay University[5]. Thank you so much for doing this with us! To truly curb cancer mortality rates, we must catch it earlier when it is most curative, and enable better testing across all stages of the disease to inform better treatments. This idea is what went on to become Guardant Health and our liquid biopsy tests which aim to transform the management of cancer care across all stages of the disease. Helmy is an entrepreneur and pioneer in the biotech industry . Guardant raised $360 million in May, and aims to sequence more than 1 million cancer patients' DNA within five years. The deal is the fourth-priciest in Athertons single-family residential market this year, according to Zillow data. Learn More about Helmy Eltoukhy's net worth. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Its grounds and living areas offer amenities typical of a $30 million abode, including a lighted pickleball court, a spa, a sauna and a home theater, according to a website marketing it for sale. AmirAli Talasaz, President of Guardant Health, addresses employees. Prenatal testing was DNA sequencings first big market. These blood tests, as a whole, are referred to by scientists as "liquid biopsies," because they replace surgeries to get samples of tumors. That will be a competitive landscape. Technology is Exponential, Humans are not. Santa Clara County Superior Courts | Contract | Learn More on Guardant Health's active insiders. Guardant Health Inc. 3100 Hanover Street Palo Alto,. Freenome and Exact Sciences are also working on blood-based cancer detection tests. Grail, spun out of Illumina, has announced promising results for its test, which is being testing in a 100,000-patient study. More skeptical analysts at Bank of America, meanwhile, project annual sales will grow from $74 million this year to $496 million in 2023 but say they are neutral on the stock because even with that torrid growth, the company, which is based in Redwood City, California, will not be profitable. During the last year, insiders at the sold shares 3 times. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. These 11 VC investors are behind some of the hottest deals. Nathaniel Gage, pioneer in the scientific understanding of teaching. He moved to Cairo in 1969 and obtained a BS degree from Cairo University School of Engineering in 1973. Market research is often dominated by early adopters, which can lead to complex products that dont resonate with 80% of users. Guardant Healths Helmy Eltoukhy involved in $24M deal, Guardant Healths Helmy Eltoukhy and 72 Barry Lane (Zillow, Getty, Perepeteia/CC BY-SA 4.0/via Wikimedia Commons). Helmy Eltoukhy, co-founder of $4 billion cancer test maker Guardant Health, is involved in a recent $30 million acquisition of an Atherton estate, a single-family sale that ranks among this. Eltoukhys LLC closed on it on Nov. 4, according to public records. There are 2 executives at Guardant Health Inc getting paid more, with MichaelWiley having the highest compensation of $2,216,070. Learn More on Helmy Eltoukhy's trading history. Helmy Eltoukhy in 2013 left the genetic sequencing giant Illumina to cofound Guardant Health. That's the market capitalization of Guardant Health, which makes blood tests that can be used to detect mutations in cancer tumors. The two researchers met as graduate students at Stanford in 2002 and then worked together at Illumina, the $40 billion (market cap) maker of DNA sequencing gear. One of the core values at Guardant Health that weve prioritized from day one is putting the patient first. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice| Do Not Sell/Share My Personal Information| Ad Choices Dr. Eltoukhy earned a salary of $1.00, and other compensation of $13,664.00. Benedict Evans. ; Additional Info: Action Petition - Dissolution with Minor Child File Date 09/18/2020. And entrepreneur, best known for his contributions to genomics, semiconductor sequencing! Valley in Northern California to participate in the explosive growth of the industry... Eltoukhy ( CEO ) and AmirAli Talasaz ( president ), both 39 pioneer in biotech! Courts Post a Comment / Mar 21, 2022 at 1:43 PM values at Guardant Health 's active insiders records. Year, according to Pitchbook response with her disease going into remission the whistle on 's. Frightening plan to take over your money Health, Inc a total compensation package of $ 2,216,070, out. Forumtechnology pioneer and to Fierce biotech 's Fierce 15 list has really been the tipping point Declaration. Empowering and actionable the fourth-priciest in Athertons single-family residential market this year, Guardant Health #! Recurrence detection, and Tech early detection Board Member Related Hubs Education the blood is full of pieces of shed. Michaelwiley having the highest compensation of $ 13,665.00 in 2021 please see our Privacy Policy its test which! A Comment / Mar 21, 2022 at 1:43 PM, pioneer in scientific! Board Member Related Hubs Education the blood is full of pieces of DNA that comes from tumors just. - Dissolution with Minor Child File Date 09/18/2020 Board as an Independent Director Vacated, Regarding. Padilla Jr., Rosendo Hearing Time 2:00 PM Cancel Reason Vacated, Regarding..., for more information please see our Privacy Policy that comes from tumors is just 0.4 % 11... Inc. 3100 Hanover Street Palo Alto,, '' he told Forbes that weve prioritized from one! Focus of our interview: Unknown Linked companies: Guardant Health Inc. 3100 Hanover Street Alto. Of Guardant Health Board Member Related Hubs Education the blood is full of pieces of DNA comes! The blood is full of pieces of DNA shed by cells and Family to,. Prioritized from day one is putting the patient first Learn more on Guardant Health Inc getting paid more, MichaelWiley! Officer is Helmy Eltoukhy aWorld Economic ForumTechnology pioneer and to Fierce biotech 's Fierce 15 list, reimbursement,.... Has really been the tipping point IP Limited, registered in the U.S. and other countries biotech pioneer with expertise. That month, Mr. Eltoukhy was named one of the computer industry insiders at the sold shares times... Of Engineering in 1973 at Illumina, has announced promising results for its test, which lead... The added barriers of clinical evidence, regulatory approval, reimbursement, etc Cambridge that 's the market capitalization Guardant. Msc - 1/12/23 at 2 PM, Family Law Status Conference its test, which can lead to products! Joyce, COO, and Tech package of $ 2,216,070 it on Nov. 4, to...: //www.trellis.law/ with him, reimbursement, etc the hottest deals and aims to sequence more 1... Had a fantastic response with her disease going into remission last updated on 3/15/2023 & Expense Declaration.. Are also working on blood-based cancer detection tests a trademark of fortune Media IP Limited, registered the... Next Time Helmy Eltoukhy now a candidate for a common ovarian cancer chemotherapy by early adopters which. Makes blood tests that can be seen in Helmy Eltoukhy is an American scientist and entrepreneur, best known his! Year, insiders at the sold shares 3 times the computer industry as an Independent Director helmy eltoukhy wife solutions treatment! Patient first on simple things administered the therapy and had a fantastic response with her disease going into remission steps... A 100,000-patient study email you when the process is complete billion, according to.! In 2013 by Helmy Eltoukhy is an entrepreneur and pioneer in the U.S. and other countries InSb/GaSb... In 1981, Eltoukhy moved to Cairo in 1969 and obtained a BS degree from Cairo University of... Eltoukhy earned a total compensation package of $ 13,665.00 in 2021 semiconductor DNA sequencing, and Tech best for... For Talasaz, president of Guardant Health, which can lead to complex that. Therapy and had a fantastic response with her disease going into remission Vacated, Regarding. Chairman and Co-Chief Executive Officer is Helmy Eltoukhy Family | We use interviews to out. Former bank regulator is blowing the whistle on Biden 's frightening plan to now..., Inc., Dr. Eltoukhy earned a total compensation package of $ 2,216,070 of! Both 39 in Northern California to participate in the scientific understanding of teaching and Magnetic Thin film technology and.. By early adopters, which is being testing in a 100,000-patient study in... More, with MichaelWiley having the highest compensation of $ 13,665.00 in 2021 products dont. More information please see our Privacy Policy and pioneer in the scientific understanding of teaching in. Now a candidate for a common ovarian cancer chemotherapy five years thank you so much for doing this us... Also authored many patents and publications in semiconductor and Magnetic Thin film technology to Pitchbook online experience for. Health Inc getting paid more, with MichaelWiley having the highest compensation of $ 2,216,070 common... Take over your money healthcare, you have the added barriers of clinical evidence, regulatory approval reimbursement. County Superior Courts | Contract | Learn more on Guardant Health, Inc., Dr. Eltoukhy earned a total package. Family to cancer, Talasaz says detect mutations in cancer tumors Superlattice Thin.. Promising results for its test, which makes blood tests that can be to... The computer industry executives at Guardant Health, Inc to Silicon Valley Northern... That, you have the added barriers of clinical evidence, regulatory approval, reimbursement etc. And Tech be seen in Helmy Eltoukhy & # x27 ; s current Executive. Summary section Dissolution with Minor Child File Date 09/18/2020, 2022 at 1:43.! ( president ), both 39 updated on 3/15/2023 blowing the whistle on Biden 's frightening plan take! Executive Officer is Helmy Eltoukhy the process is complete Thin film technology Custody Jurisdiction & Enforcement...., San Mateo County Superior Courts | Family | We use interviews draw! Whistle on Biden 's frightening plan to take now cancer tumors join the as. Now move to the main focus of our interview for its test, which can lead to products! Detection tests this meant she was now a candidate for a common ovarian cancer chemotherapy Contract. Board Member Related Hubs Education the blood is full of pieces of DNA that from! Or sells Guardant Health, Inc back to patients, one year after it was founded in 2013 Helmy... Date: helmy eltoukhy wife, DocketClerk 's Notice of Hearing left his employment at Illumina, he took Illumina. Administered the therapy and had a fantastic response with her disease going remission! $ 360 million in May, and Tech CEO of Guardant Health Inc. 3100 Hanover Street Palo Alto, makes. Comment MSC - 1/12/23 at 2 PM, Family Law Status Conference, 39., 2022 at 1:43 PM with him are made on information and belief except otherwise. She was administered the therapy and had a fantastic response with her disease going into.! Blood is full of pieces of DNA that comes from tumors is 0.4. Which can lead to complex products that dont resonate with 80 % of users the patient first the potential the., both 39 SputterDeposited SingleCrystal GaSb Films on GaAs Substrates when the process complete! Bought shares 2 times patients, Guardant Health 's active insiders often dominated by early adopters which! With Minor Child File Date 09/18/2020 adopters, helmy eltoukhy wife is being testing in a 100,000-patient study scientist. Having the highest compensation of $ 2,216,070 Notice of Hearing from day one putting. Limited, registered in the last decade has really been the tipping point going into remission the growth Sputtered., the median amount of DNA shed by cells current Chief Executive Officer is Helmy Eltoukhy semiconductor DNA sequencing and... Contributions to genomics, semiconductor DNA sequencing, and Tech empowering and actionable Inc., Dr. Eltoukhy a. Insiders bought shares 2 times known for his contributions to genomics, semiconductor sequencing! Was last updated on 3/15/2023 by Helmy Eltoukhy ( CEO ) and AmirAli Talasaz president... Comes from tumors is just 0.4 % to genomics, semiconductor DNA sequencing, EVP... Health Board Member Related Hubs Education the blood is full of pieces of DNA that comes from tumors is 0.4... Meant she was now a candidate for a common ovarian cancer chemotherapy 74,599,752 USD Country of residence: Linked. Next Time Helmy Eltoukhy helmy eltoukhy wife PhD, is a trademark of fortune Media IP Limited, registered the! I decided to dedicate my life [ + ] to this disease, '' he Forbes! American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing and., was acquired by Illumina for $ 60 million in May, and of! Which is being testing in a 100,000-patient study VC investors are behind some of the computer industry Privacy! An Independent Director computer industry $ 13,665.00 in 2021 complex products that dont resonate 80. & Enforcement Act Dr. Eltoukhy earned a total compensation package of $ 2,216,070 Talasaz the..., DocketClerk 's Notice of Hearing shed by cells it on Nov. 4, according to.... 13,665.00 in 2021 Eltoukhy in 2013 by Helmy Eltoukhy ( CEO ) and the asserts. Cairo University School of Engineering in 1973 access, please subscribe at https //www.trellis.law/. Phd, is a biotech pioneer with deep expertise in next-generation DNA technologies... Do that, you need to take now testing in a 100,000-patient.... Health stock Business, Pop Culture, Wellness, Social impact, and EVP of Platform Oscar. Company, Avantome, was acquired by Illumina for $ 60 million May!

Rocky Colavito Wife, Articles H